Confidential and Proprietary Information

Amgen’s most valuable asset, after its staff members, is its Proprietary and Confidential Information. If this information is improperly disclosed to competitors or others, that disclosure may severely impede Amgen’s ability to conduct its business. Detailed explanations regarding Proprietary and Confidential Information, as well as Restricted Information (which is often both Proprietary and Confidential and nearly always relates to a trade secret) are provided in the Confidential and Proprietary Information Policy. Please refer to that policy for additional details regarding the policy and the obligations of individuals subject to the policy.

Staff members should exercise extreme caution when discussing Amgen, its products, data or plans with anyone outside the Company.

The release of Confidential, Proprietary or Restricted Information or related data, including speeches or papers or any other written or oral disclosure, which pertains to these subjects, to anyone, including individuals, companies, or the public at large, requires the prior approval of the Law Department. Additional departmental clearance procedures may apply.

Written confidentiality agreements must be negotiated and concluded with all outside companies and individuals before any Proprietary, Confidential or Restricted Information is received, discussed, or revealed, or before any non-Company personnel are allowed access to areas or materials from which knowledge could be obtained. Agreements of this nature require the prior approval of the Law Department.

In addition, some Amgen staff members may possess, come to possess, or be presented with the opportunity to obtain information that is proprietary and/or confidential to third parties, such as competitors of Amgen, former employers, or Amgen’s suppliers, customers and partners. It is important that such third-party information be treated in accordance with the law and consistent with any contractual obligations that exist between any or all of the Amgen staff members, the third party and Amgen. Staff members may not use, or ask any third party to use, unlawful means and may not use, or ask any third party to use, misrepresentation, deception, theft, spying, or bribery to obtain any third party’s proprietary or confidential information.

Upon joining the Company, each Amgen staff member executes a Proprietary Information and Inventions Agreement. Staff members should carefully review the terms of that agreement to understand their rights and obligations with regard to Amgen Proprietary, Confidential and/or Restricted Information developed by them or others.

Every individual who conducts business for or on behalf of Amgen, at every Amgen site worldwide, is required to follow all laws and Amgen policies applicable to him or her, and should exert due diligence in preventing and detecting violations of such laws and policies.